BGB-16673 showed high overall response rates in relapsed/refractory CLL/SLL, with a notable 94.4% response at the 200-mg dose level. Safety analysis revealed that 95.6% of patients experienced ...

Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs December 7, 2025 ...

Women who used a GLP-1 prior to pregnancy and stopped therapy 1 to 2 years before delivery had increased risk for preeclampsia, but reduced risk for developing gestational diabetes, according to study ...

On December 4, 2025, Sky Labs (CEO Jack Byunghwan Lee) announced that its ring-type blood pressure monitoring device, 'CART BP', has successfully measured blood pressure in a microgravity environment ...

Ontada is highlighting its research capabilities at ASH with nine accepted abstracts on topics such as real-world uptake and patient characteristics of bispecific antibodies in relapsed / refractory ...

March of Dimes, the national leader in maternal and infant health research, today announced the winners of the 2025 Basil O'Connor Starter Scholar Research Awards, which recognize exceptional ...

With Holiday gatherings, food-filled countertops, and holiday décor just around the corner, Pumpkin, a leading provider of pet insurance and preventive care, is urging pet parents to be extra vigilant ...

Executives at D-Wave Quantum are cashing out their stock.

Discusses Positive Topline Results from Phase III DRAGON Trial of Tinlarebant in Stargardt Disease December 1, 2025 8:00 ...

Multiple targets identified and confirmed for drill testing at Luanshya West. Successful drone magnetic survey, in-fill and ...

Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...

Angkor Gold ( ($TSE:ANK) ) just unveiled an update. Angkor Resources Corp. has identified Mussel Basin as a new target for exploratory drilling on ...